Abstract
The E2 gene of the branched-chain α-keto acid dehydrogenase (BCKDH) complex was studied at the molecular level in three patients with intermittent maple syrup urine disease (MSUD). All three patients had higher BCKDH activity than did those with the classical phenotype. In the first patient, a single base substitution from A to G in intron 8 created a new 5′ splice site and caused an insertion of 126 nucleotides between exons 8 and 9 by activating an upstream cryptic 3′ splice site in the same intron. The predicted mRNA encoded a truncated protein with 282 amino acids including 4 novel ones at the carboxyl terminus, compared with the normal protein with 421 amino acids. In vitro, the region from the patient but not from a normal control was recognized and was recovered as a novel exon, indicating that the single substitution was responsible for incorporation of the region into mRNA. This mutation probably supports an exon definition model in which the spliceosome recognizes a 3′ splice site and then scans downstream for an acceptable 5′ splice site, thereby defining an exon. The second patient was homozygous for a G to T transversion at nucleotide 1463 in exon 11, which predicted a substitution of the termination codon by a leucine residue and the addition of 7 extra amino acids at the carboxyl terminus. For each mutation, these two patients were homozygous and their parents were heterozygous. The third patient was a compound heterozygote for a C to G transversion at nucleotide 309 in exon 4 and a G to A transition at nucleotide 1165 in exon 9, causing an Ile-to-Met substitution at amino acid 37 and a Gly-to-Ser substitution at amino acid 323, respectively. Taken together, these results indicate that the molecular basis of intermittent phenotype MSUD in some patients can be due to mutations in the E2 gene, giving rise to a low but significant residual activity of the BCKDH complex.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Received: October 29, 1997 / Accepted: November 27, 1997
Rights and permissions
About this article
Cite this article
Tsuruta, M., Mitsubuchi, H., Mardy, S. et al. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain α-keto acid dehydrogenase complex. J Hum Genet 43, 91–100 (1998). https://doi.org/10.1007/s100380050047
Published:
Issue Date:
DOI: https://doi.org/10.1007/s100380050047
This article is cited by
-
Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?
Journal of Assisted Reproduction and Genetics (2022)
-
Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAFV600E expression
Oncogene (2020)
-
Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity
Orphanet Journal of Rare Diseases (2020)
-
Deep intronic mutations and human disease
Human Genetics (2017)
-
Present and future of antisense therapy for splicing modulation in inherited metabolic disease
Journal of Inherited Metabolic Disease (2010)